Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis

Dimitrios S Karagiannakis1, Jiannis Vlachogiannakos2, Georgios Anastasiadis3

  • 1Academic Department of Gastroenterology, Medical School of Athens, Laikon General Hospital, 17 Aghiou Thoma Street, 11527, Athens, Greece. d_karagiannakis@hotmail.com.

Insights

Left ventricular diastolic dysfunction (LVDD) is common in cirrhosis and linked to worse patient outcomes. Early detection and strict follow-up are crucial for managing cirrhotic cardiomyopathy and improving prognosis.

Area of Science:

  • Cardiology
  • Hepatology
  • Medical Diagnostics

Background:

  • Left ventricular diastolic dysfunction (LVDD) is a key feature of cirrhotic cardiomyopathy.
  • The prognostic significance of LVDD in liver cirrhosis remains incompletely understood.

Purpose of the Study:

  • To assess the association between LVDD and liver disease characteristics.
  • To determine the impact of LVDD on the clinical outcomes of cirrhotic patients.

Main Methods:

  • Echocardiography, specifically tissue Doppler imaging, was used to evaluate cardiac function in 45 cirrhotic patients.
  • LVDD diagnosis followed the American Society of Echocardiography guidelines.
  • Patients were followed for 2 years, with mortality or liver transplantation as endpoints.

Main Results:

  • LVDD was present in 38% of patients, with severity correlating with the Child-Pugh score.
  • Patients with LVDD exhibited significantly poorer survival rates (p=0.013).
  • Low albumin and the presence of LVDD were independent predictors of mortality.

Conclusions:

  • Left ventricular diastolic dysfunction is a frequent complication in cirrhosis.
  • LVDD is associated with a worse prognosis in cirrhotic patients.
  • Patients diagnosed with LVDD require close medical monitoring.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
776
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K